BIBBINSTRUMENTS AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.5 SEK | +14.58% |
|
+15.06% | +74.05% |
| 05-20 | Sweden's BiBBInstruments to Issue SEK10 Million Shares | MT |
| 05-17 | BiBBInstruments Expands Clinical Evaluation of Endoscopy Instrument in Scandinavia | MT |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 116 | 116 | 97.15 | 175.4 | 165.6 | 130.9 |
| Enterprise Value (EV) 1 | 103.7 | 109.9 | 77.83 | 153.5 | 158.7 | 117.5 |
| P/E ratio | -29 x | -15 x | -6.38 x | -12.6 x | -16.1 x | -10.8 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 907 x | 259 x | 196 x | 728 x | 10,351 x | - |
| EV / Revenue | 811 x | 245 x | 157 x | 637 x | 9,916 x | - |
| EV / EBITDA | - | -11,229,858 x | -6,472,975 x | -12,173,390 x | -15,772,784 x | -10,700,599 x |
| EV / FCF | -31.7 x | -12.8 x | -5.55 x | -13.7 x | -14.3 x | -10.2 x |
| FCF Yield | -3.16% | -7.82% | -18% | -7.31% | -6.98% | -9.79% |
| Price to Book | 8.4 x | 4.65 x | 3.42 x | 5.52 x | 7.69 x | 4.12 x |
| Nbr of stocks (in thousands) | 8,230 | 8,230 | 16,245 | 19,485 | 19,485 | 22,813 |
| Reference price 2 | 14.10 | 14.10 | 5.980 | 9.000 | 8.500 | 5.740 |
| Announcement Date | 30/05/18 | 01/05/19 | 21/05/20 | 21/05/21 | 20/05/22 | 19/05/23 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.128 | 0.448 | 0.496 | 0.241 | 0.016 | - |
| EBITDA | - | -9.783 | -12.02 | -12.61 | -10.06 | -10.98 |
| EBIT 1 | -5.098 | -9.787 | -12.06 | -12.74 | -10.27 | -11.28 |
| Operating Margin | -3,982.81% | -2,184.6% | -2,431.05% | -5,287.97% | -64,193.75% | - |
| Earnings before Tax (EBT) 1 | -5.132 | -9.787 | -12.06 | -12.74 | -10.27 | -11.28 |
| Net income 1 | -4.005 | -7.748 | -15.22 | -12.74 | -10.27 | -11.28 |
| Net margin | -3,128.91% | -1,729.46% | -3,069.35% | -5,287.97% | -64,193.75% | - |
| EPS 2 | -0.4866 | -0.9414 | -0.9372 | -0.7134 | -0.5271 | -0.5332 |
| Free Cash Flow 1 | -3.278 | -8.589 | -14.02 | -11.22 | -11.08 | -11.5 |
| FCF margin | -2,560.74% | -1,917.16% | -2,825.66% | -4,654.77% | -69,239.84% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 30/05/18 | 01/05/19 | 21/05/20 | 21/05/21 | 20/05/22 | 19/05/23 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 12.3 | 6.19 | 19.3 | 21.9 | 6.96 | 13.5 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -3.28 | -8.59 | -14 | -11.2 | -11.1 | -11.5 |
| ROE (net income / shareholders' equity) | -53.8% | -40% | -57% | -42.3% | -38.5% | -42.3% |
| ROA (Net income/ Total Assets) | -37.7% | -28.5% | -25.9% | -24.9% | -22.5% | -24.2% |
| Assets 1 | 10.62 | 27.18 | 58.78 | 51.16 | 45.74 | 46.61 |
| Book Value Per Share 2 | 1.680 | 3.030 | 1.750 | 1.630 | 1.100 | 1.390 |
| Cash Flow per Share 2 | 1.490 | 0.7500 | 1.190 | 1.120 | 0.3600 | 0.5900 |
| Capex | - | - | - | 0.61 | 0.19 | 0.27 |
| Capex / Sales | - | - | - | 252.7% | 1,193.75% | - |
| Announcement Date | 30/05/18 | 01/05/19 | 21/05/20 | 21/05/21 | 20/05/22 | 19/05/23 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +74.05% | 13.6M | |
| -21.31% | 17.75B | |
| -42.69% | 2.85B | |
| +21.31% | 1.92B | |
| -7.25% | 1.58B | |
| -18.78% | 952M | |
| -22.39% | 888M | |
| +4.64% | 828M | |
| -26.49% | 611M | |
| +19.10% | 591M |
- Stock Market
- Equities
- BIBB Stock
- Financials BiBBInstruments AB
